Japanese company profile · 9265

ヤマシタヘルスケアホールディングス株式会社

The original Japanese company name is shown; no English name has been verified.

FY2025 · fiscal year ended May 2026Latest filing date: 2026-08-25

What does this company do?

What does this company do?

The latest available public filing reports Medical equipment sales, Medical equipment manufacturing and sales, Medical mall business. The original Japanese company name is shown with the source information.

This company's largest reported business by revenue in FY2025 was Medical equipment sales.

The business with the highest reported segment profit in FY2025 was Medical equipment sales.

FY2025 · fiscal year ended May 2026 · View original filing ↗ The source document may be in Japanese.

Reported company-wide figures

Company revenue
¥64.15B ↗
FY2025 · fiscal year ended May 2026
Operating profit
¥737M ↗
FY2025 · fiscal year ended May 2026
Comparable margin
1.1% ↗
FY2025 · fiscal year ended May 2026

JGAAP · Consolidated company-wide

Company profile

Company profile

Identity

Securities code
9265
EDINET code
E33393
Corporate number
2290001079821
Listing status
Listed
Industry (EDINET filer classification)
Wholesale trade

Location and fiscal year

Headquarters
福岡市博多区 · As filed in Japanese
Fiscal year end
5month
Latest fiscal year
FY2025
Accounting standard
JGAAP
P16 data snapshot
2026-11-07

Company size

Employees (consolidated)
617 people (FY2025)
Employees (non-consolidated)
31 people (FY2025)
Capital stock
JPY 494.0 million (FY2025)

Official information

Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab

Business structure

How does it make money?

Revenue leader and profit leader

Medical equipment sales

FY2025 · fiscal year ended May 2026 · Business Sales Operating profit
BusinessSalesShare of company salesOperating profitMargin
Medical equipment sales¥63.87B ↗99.6%99.6%Sales to external customers: ¥63.87B ↗¥2.13B ↗3.3%
Medical equipment manufacturing and sales¥210M ↗0.3%0.3%Sales to external customers: ¥207M ↗−¥185M ↗-88.1%
Medical mall business¥74M ↗0.1%0.1%Sales to external customers: ¥74M ↗¥7M ↗9.5%

All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended May 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.

Company revenue

Company-wide trend

Company revenue

JGAAP · Consolidated
  1. FY202185.5¥55.15B
  2. FY202290.2¥58.2B
  3. FY202395.5¥61.55B
  4. FY2024100.0¥64.49B
  5. FY202599.5¥64.15B

Company operating profit

JGAAP · Consolidated
  1. FY202180.5¥930.75M
  2. FY2022100.0¥1.16B
  3. FY202383.7¥967M
  4. FY202472.5¥838M
  5. FY202563.8¥737M

Only reported years are shown. Missing years are left blank; accounting standards and scopes are kept in separate series.

Reported Sales by business over time

Reported Sales by business over time

Fiscal yearFY2021FY2022FY2023FY2024FY2025
Medical equipment sales¥54.8B¥57.85B¥61.22B¥64.19B¥63.87B
Medical equipment manufacturing and sales¥287.87M¥286M¥267M¥219M¥210M
Medical mall business¥68.64M¥69M¥68M¥72M¥74M

All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.

What is growing?

What is growing?

Business revenue growth

This describes a reported period; it is not a forecast.

What has changed?

What has changed?

A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.

Source

Company profile

These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.

  • Growth35
    Peer-position scoreFY2025
  • Profitability12
    Peer-position scoreFY2025
  • Business concentration99
    Peer-position scoreFY2025
  • Business change22
    Peer-position scoreFY2021→FY2025
  • Cash generation15
    Peer-position scoreFY2025
  • Growth persistence43
    Peer-position scoreFY2021→FY2022, FY2022→FY2023, FY2023→FY2024, FY2024→FY2025

Next

Ask about this company

Source

Public filing

FY2025 · fiscal year ended May 2026

The source document may be in Japanese.

Filing ID: S100YXFY

View original filing ↗

根拠となる資料